CVS Pharmacy & Business News

Image description

Report: CVS Health says new Amgen data could expand Repatha eligibility

Based on new data about Amgen’s PCSK9 inhibitor cholesterol drug Repatha, CVS Health’s chief medical officer, Dr. Troyen Brennan, told Reuters that the number of patients eligible to use the drug could quadruple. He noted that the data — published in the New England Journal of Medicine and showing Repatha’s ability to reduce heart attack, stroke, heart disease deaths, chest pain hospitalizations and stent and bypass procedures by 15% — would need to be reviewed by heart experts. (Reuters)
 

Image description

CVS Health names Jon Roberts EVP, COO

Roberts, who currently serves as president of CVS Caremark, will work in his new role to deliver differentiated products and services to help people on their path to better health, the company said.